吉西他滨联合多西他赛三线治疗复发小细胞肺癌的临床观察(3)
[6] Ettinger D，Jotte R.，Lorigan P，et al.Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer[J].J Clin Oncol，2010，28：2598-2603.[7] Ando M，Kobayashi K，Yoshimura A，et al.Weekly administration of irinotecan(CPT-11)plus cisplatin for refractory or relapsed small cell lung cancer[J].Lung Cancer ......
您现在查看是摘要页，全文长 2764 字符。